Advisory Board and Editors Infectious Diseases
Eli N. Perencevich
Professor of Internal Medicine and Epidemiology at the University of Iowa Carver College of Medicine. Director, Center for Comprehensive Access and Delivery Research & Evaluation (CADRE), Iowa City VA Healthcare System. Primary research areas: infection prevention, multi-drug resistant bacteria, Staphylococcus aureus
Tomas Perez-Acle
Biologist, PhD in Biotechnology. Director of the Centro BASAL Ciencia & Vida. Head Researcher of the Computational Biology Lab (dLab) at Fundacion Ciencia & Vida, Santiago, Chile. Research Professor at Facultad de Ingeniería y Tecnología, Universidad San Sebastián.
Brett E Pickett
Dr. Brett Pickett is an Assistant Professor in the Microbiology and Molecular Biology Department at Brigham Young University. He completed his B.S degree in Microbiology from BYU in 2005, his Ph.D. training in Microbiology at the University of Alabama at Birmingham, and his postdoctoral training in Pathology at the University of Texas Southwestern Medical Center at Dallas. He then obtained additional experience in industry, and at the J. Craig Venter Institute, where he led investigative studies in viral comparative genomics and the human transcriptional response during viral infection. His research develops data mining methods, applies machine learning techniques, and use advanced statistical workflows to better understand how human cells respond during infection.
Ayyalusamy Ramamoorthy
Prof. Ramamoorthy is a Professor of Chemistry a Robert W Parry Collegiate Professor of Chemistry and Biophysics at the University of Michigan, Ann Arbor. He holds or has held the positions listed below.
Associate Director of Biophysics and an elected fellow of AAAS.
Hans Fischer Senior Fellow, Technical University of Munich, 2015
Rackham Faculty Recognition Award, 2012
American Association for the Advancement of Science Fellow, 2009
Japan Society for the Promotion of Science Fellow, 2009
Willsmore Fellow, University of Melbourne, Australia, 2009
NSF Career Development Award
Distinguished Visiting Professor, Osaka University (2005)
Distinguished Visiting Professor, Kyoto University (2008)
Distinguished Visiting Professor, Max-Planck Institute, Mainz (2009)
Morteza Saki
Dr. Morteza Saki is a researcher within the Department of Microbiology at the Ahvaz Jundishapur University of Medical Sciences,Ahvaz, Iran.
His research focuses on the mechanisms of antimicrobial resistance in ESKAPE Pathogens, especially Klebsiella pneumoniae.
Martina Schroeder
Dr Martina Schroeder is a Lecturer and Head of the Host-Pathogen Interaction Lab at Maynooth University. Her research addresses viral recognition, innate immune signaling pathways, and the roles of DEAD-box proteins in immunity. Previously Dr Schroeder conducted postdoctoral research with Prof. Andrew Bowie at Trinity College Dublin. In 2007, she was awarded a postdoctoral career development fellowship by the Irish HRB. She completed her PhD at the Charité University Hospital in Berlin in 2003.
Arif J Siddiqui
Dr. Arif Jamal Siddiqui is an Associate Professor and Principal Investigator at the Department of Biology, College of Science, University of Hail, Saudi Arabia. He received his PhD from CSIR-Central Drug Research Institute, Lucknow, India in 2015. From 2015 to 2018, he worked as a Post-Doctoral Fellow at Texas Tech University Health Sciences Center, Lubbock, Texas, United States of America.
He has more than 8 years of experience in research, teaching and administration. In his professional work, he has received research grants as a Principal Investigator from various renowned organizations. He has successfully published more than 100 publications in internationally recognized peer-reviewed prestigious journals, published several book chapters for internationally renowned publishers and presented many articles and posters in various conferences/workshops worldwide. He has published numerous papers in the fields of parasitology, immunology, herbal medicine, vaccine development, drug discovery and natural products with a specialization in anti-parasitic, antiviral, anticancer and antibacterial agents. Furthermore, he is a member of The Indian Science Congress Association, India and the Annals of Parasitology, Poland. He has reviewed more than 250 manuscripts and he also currently holds various editorial positions (Academic, Associate, Guest and Review Editor) in various reputable journals and has edited more than 150 manuscripts.
Joana C Silva
My group applies evolutionary genetics and genomic sciences to basic research on species evolution and translational research of infectious diseases. I have been studying infectious disease genomics since the early 2000's. At The Institute for Genomic Research (TIGR) I was part of the team that launched the field of parasite genomics, with work on several Plasmodium and trypanosomatid species, Theileria parva and Trichomonas vaginalis. At the Institute for Genome Sciences, University of Maryland School of Medicine, we have ongoing projects on a variety of parasites in the phylum Apicomplexa. These include the causative agents of malaria in humans (genus Plasmodium), tropical theileriosis and East Coast fever in cattle (genus Theileria), human babesiosis (genus Babesia), and human cryptosporidiosis (genus Cryptosporidium). Ongoing projects include the study of species biology and the nature of host-parasite interactions, based on the generation and analyses of genomes, and studies of vaccine efficacy and vaccine design, drug resistance and the evolution of parasite populations, informed by population genomics data. Our research is funded by NSF, NIH, USDA and the Bill and Melinda Gates Foundation.
Rajesh Kumar Singh
Dr. Rajesh Kumar Singh received his BPharm (2003) and MPharm (2005) from UIPS, Panjab University, Chandigarh. He started to teach pharmaceutical chemistry at the Shivalik College of Pharmacy, Nangal, in 2006, where he completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar. His major areas of research interest are computer-aided drug-design, polymer-drug conjugates for targeted delivery to CNS and cancerous cells, antimalarial therapeutic agents, and green chemistry approaches for chemical synthesis. Dr. Singh has over 15 years of teaching experience and has guided one 03 Ph.D. and 20 PG students. He is currently guiding 02 PhDs and 02 MPharm students. He has published more than 70 peer-reviewed SCI/SCOPUS-indexed scientific papers with a total JCR Impact Factor of more than 200 in various chemistry and pharmacy journals such as European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica-B, Bioorganic Chemistry, Biomedicine and Pharmacotherapy, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Mini-Reviews in Medicinal Chemistry, Pharmaceutical Research, Med. Chem. Res., J. Enzyme Inhi. Med Chem., Res. Chem. Intermediate etc as main or corresponding author. He currently serves as an Editorial Advisory Board Member of 10 international journals, including the SCI-indexed MRMC (Bentham) and PeerJ. He has received the Publon Award 2016, 2017 and the Publon "Excellent Peer Reviewer Award" for outstanding reviewing of more than 290 research papers in different international journals of ACS, RSC, Springer, Elsevier, Dove, Informa, and Bentham whose Impact Factor varies from 1.0 to 12.5. He also has over 60 National and International Conference Abstracts, 5 Books, 5 Best Paper Presentation Awards, 1 Travel Grant to attend International Conferences, and 5 Research Projects funded by Indian Government Agencies. He is also on the panel of international reviewers for research proposals for Royal Society Grants. He is also serving as a PUBLON ACADEMY MENTOR and a BENTHAM BRAND AMBASSADOR. He has been recognized by the Editors as an OUTSTANDING REVIEWER for RSC Medicinal Chemistry journal (IF 4.1, Q1) and also for BENTHAM PUBLISHER in 2023. His name is recently featured in the list of top 2% scientists (2023) ranked by team of Stanford University, USA and Elsevier.
Reema Singh
A highly accomplished Computational Biologist and Bioinformatician with over 19 years of research expertise. My professional focus is on One Health bioinformatics, using pathogen transcriptomics and genomic surveillance to investigate and control infectious threats and antimicrobial resistance. My career has been marked by a strong track record of developing impactful tools and pipelines, including the Dlact antimicrobial resistance gene database and the Gen2Epi computational pipeline. Currently, as a Bioinformatician and Data Manager at the Vaccine and Infectious Disease Organization (VIDO), I apply my skills to analyze large-scale transcriptomics data and elucidate host-pathogen interactions in both human and animal populations
Srinivas Sistla
Dr. Srinivas Sistla is Director of Laboratories within the Microbiology and Immunology Department at State University of New York (SUNY) Stony Brook. He is a trained Biophysics and Drug Discovery Scientist, with experience working for industry and academia.
Dr. Sistla obtained his PhD in 2008 (Biotechnology and Biophysics) and is interested in the following fields of research; Bioactive Peptides, Biochemistry, Biophysics, Medical Biochemistry and Metabolomics, and Surface Plasmon Resonance.